The Use of ECT and MST in treating depression

References

• Anderson, E.L. & Reti, I.M. (2009). ECT in pregnancy: A review of the literature from 1941 to 2007. Psychosomatic Medicine, 71, 235–242.
   PubMed Web of Science ®Google Scholar
• Andrade, P., Noblesse, L.H., Temel, Y., Ackermans, L., Lim, L.W., Steinbusch, H.W. & Visser-Vandewalle, V. (2010). Neurostimulatory and ablative treatment options in major depressive disorder: A systematic review. Acta Neurochirurgica, 152, 565–577.
   PubMedGoogle Scholar
• Anttila, S., Viikki, M., Huuhka, K., Huuhka, M., Huhtala, H., Rontu, R., Lehtimaki, T. & Leinonen, E. (2009). TPH2 polymorphisms may modify clinical picture in treatment-resistant depression. Neuroscience Letters, 464, 43–46.
   PubMed Web of Science ®Google Scholar
• Antunes, P.B. & Fleck, M.P. (2009). Clinical outcomes and quality of life in patients submitted to electroconvulsive therapy. Journal of ECT, 25, 182–185.
   PubMedGoogle Scholar
• Azuma, H., Yamada, A., Shinagawa, Y., Nakano, Y., Watanabe, N., Akechi, T. & Furukawa, T.A. (2011). Ictal physiological characteristics of remitters during bilateral electroconvulsive therapy. Psychiatry Research, 185, 462–464.
   PubMedGoogle Scholar
• Bailine, S., Fink, M., Knapp, R., Petrides, G., Husain, M.M., Rasmussen, K., Sampson, S., Mueller, M., McClintock, S.M., Tobias, K.G. & Kellner, C.H. (2010). Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatrica Scandinavica, 121, 431–436.
   PubMed Web of Science ®Google Scholar
• Bar, K.J., Ebert, A., Boettger, M.K., Merz, S., Kiehntopf, M., Jochum, T., Juckel, G. & Agelink, M.W. (2010). Is successful electroconvulsive therapy related to stimulation of the vagal system? Journal of Affective Disorders, 125, 323–329.
   PubMedGoogle Scholar
• Bayless, J.D., McCormick, L.M., Brumm, M.C., Espe-Pfeifer, P.B., Long, J.J. & Lewis, J.L. (2010). Pre- and post-electroconvulsive therapy multidomain cognitive assessment in psychotic depression: Relationship to premorbid abilities and symptom improvement. Journal of ECT, 26, 47–52.
   PubMedGoogle Scholar
• Berg, J.E. & Kononova, N. (2009). Sense of coherence in patients treated for depression with ECT. International Journal of Psychiatry in Medicine, 39, 101–112.
   PubMedGoogle Scholar
• Birkenhager, T.K., Pluijms, E.M., Ju, M.R., Mulder, P.G. & den Broek, W.W. (2010). Influence of age on the efficacy of electroconvulsive therapy in major depression: A retrospective study. Journal of Affective Disorders, 126, 257–261.
   PubMedGoogle Scholar
• Bolwig, T.G. & Fink, M. (2009). Electrotherapy for melancholia: The pioneering contributions of Benjamin Franklin and Giovanni Aldini. Journal of ECT, 25, 15–18.
   PubMedGoogle Scholar
• Brunoni, A.R., Teng, C.T., Correa, C., Imamura, M., Brasil-Neto, J.P., Boechat, R., Rosa, M., Caramelli, P., Cohen, R., Del Porto, J.A., Boggio, P.S. & Fregni, F. (2010). Neuromodulation approaches for the treatment of major depression: Challenges and recommendations from a working group meeting. Arquivos de Neuro Psiquiatria, 68, 433–451.
   PubMed Web of Science ®Google Scholar
• Bundy, B.D., Hewer, W., Andres, F.J., Gass, P. & Sartorius, A. (2010). Influence of anesthetic drugs and concurrent psychiatric medication on seizure adequacy during electroconvulsive therapy. Journal of Clinical Psychiatry, 71, 775–777.
   PubMed Web of Science ®Google Scholar
• Carney, S., Cowen, P., Geddes, J., Goodwin, G., Rogers, R., Dearness, K., Tomlin, A., Eastaugh, J., Freemantle, N., Lester, H., Harvey, A. & Scott, A. (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. Lancet, 361, 799–808.
   PubMedGoogle Scholar
• Carpenter, L., Megna, J., Herrera-Rojas, M. & Siddiqui, U. (2011). When medication fails: Neurostimulation therapies for depression. Clinical Neuropsychiatry, 8, 61–80.
   Google Scholar
• Cassidy, F., Weiner, R.D., Cooper, T.B. & Carroll, B.J. (2009). Antidepressant response to electroconvulsive therapy is sustained after catecholamine depletion. Progress in Neuro Psychopharmacology and Biological Psychiatry, 33, 872–874.
   PubMedGoogle Scholar
• Cassidy, F., Weiner, R.D., Cooper, T.B. & Carroll, B.J. (2010). Combined catecholamine and indoleamine depletion following response to ECT. British Journal of Psychiatry, 196, 493–494.
   PubMedGoogle Scholar
• Castren, E. & Rantamaki, T. (2010). The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Developmental Neurobiology, 70, 289–297.
   PubMed Web of Science ®Google Scholar
• Chakrabarti, S., Grover, S. & Rajagopal, R. (2010). Electroconvulsive therapy: A review of knowledge, experience and attitudes of patients concerning the treatment. World Journal of Biological Psychiatry, 11, 525–537.
   PubMed Web of Science ®Google Scholar
• Cinar, S., Oude Voshaar, R.C., Janzing, J.G., Birkenhager, T.K., Buitelaar, J.K. & van den Broek, W.W. (2010). The course of depressive symptoms in unipolar depressive disorder during electroconvulsive therapy: A latent class analysis. Journal of Affective Disorders, 124, 141–147.
   PubMedGoogle Scholar
• Domschke, K., Zavorotnyy, M., Diemer, J., Nitsche, S., Hohoff, C., Baune, B.T., Deckert, J., Arolt, V. & Zwanzger, P. (2010). COMT val158met influence on electroconvulsive therapy response in major depression. American Journal of Medical Genetics Part B, Neuropsychiatric Genetics, 153B, 286–290.
   PubMed Web of Science ®Google Scholar
• Dwork, A., Arango, V., Underwood, M., Ilievski, B., Rosoklija, G., Sackeim, H. & Lisanby, S.H. (2004). Absence of histological lesions in primate models of ECT and magnetic seizure therapy. American Journal of Psychiatry, 161, 576–578.
   PubMed Web of Science ®Google Scholar
• Ebert, A., Jochum, T., Ritter, J., Boettger, M.K., Schulz, S., Voss, A. & Bär, K.J. (2010). Does parasympathetic modulation prior to ECT treatment influence therapeutic outcome? Progress in Neuro Psychopharmacology and Biological Psychiatry, 34, 1174–1180.
   PubMedGoogle Scholar
• Falconer, D.W., Cleland, J., Fielding, S. & Reid, I.C. (2010). Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory. Psychological Medicine, 40, 1017–1025.
   PubMed Web of Science ®Google Scholar
• Fernandes, B., Gama, C.S., Massuda, R., Torres, M., Camargo, D., Kunz, M., ...Inês Lobato, FernandesM. (2009). Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patients. Neuroscience Letters, 453, 195–198.
   PubMed Web of Science ®Google Scholar
• Fitzgerald, P. (2008). Brain stimulation techniques for the treatment of depression and other psychiatric disorders. Australasian Psychiatry, 16, 183–190.
   PubMed Web of Science ®Google Scholar
• Fitzsimons, L., Disner, S.G. & Bress, J.N. (2009). Effective utilization and future directions for repetitive transcranial magnetic stimulation: A guide for psychiatric nurses. Journal of the American Psychiatric Nurses Association, 15, 314–324.
   PubMedGoogle Scholar
• Fountoulakis, K.N. (2010). An update of evidence-based treatment of bipolar depression: Where do we stand? Current Opinion in Psychiatry, 23, 19–24.
   PubMed Web of Science ®Google Scholar
• Frais, A.T. (2010). Electroconvulsive therapy: A theory for the mechanism of action. Journal of ECT, 26, 60–61.
   PubMed Web of Science ®Google Scholar
• Fraser, L.M., O'Carroll, R.E. & Ebmeier, K.P. (2008). The effect of electroconvulsive therapy on autobiographical memory: A systematic review. Journal of ECT, 24, 10–17.
   PubMed Web of Science ®Google Scholar
• George, M., Nahas, Z., Li, X., Kozel, F., Anderson, B., Yamanaka, K., Chae, J. & Foust, M. (2002). Novel treatments of mood disorders based on brain circuitry (ECT, MST, TMS, VNS, DBS). Seminars in Clinical Neuropsychiatry, 7, 293–304.
   PubMedGoogle Scholar
• Gibson, T.B., Jing, Y., Smith Carls, G., Kim, E., Bagalman, J.E., Burton, W.N., Tran, Q.V., Pikalov, A. & Goetzel, R.Z. (2010). Cost burden of treatment resistance in patients with depression. American Journal of Managed Care, 16, 370–377.
   PubMed Web of Science ®Google Scholar
• Girgenti, M.J., Hunsberger, J., Duman, C.H., Sathyanesan, M., Terwilliger, R. & Newton, S.S. (2009). Erythropoietin induction by electroconvulsive seizure, gene regulation, and antidepressant-like behavioral effects. Biological Psychiatry, 66, 267–274.
   PubMed Web of Science ®Google Scholar
• Gronli, O., Stensland, G.O., Wynn, R. & Olstad, R. (2009). Neurotrophic factors in serum following ECT: A pilot study. World Journal of Biological Psychiatry, 10, 295–301.
   PubMed Web of Science ®Google Scholar
• Grunze, H., Vieta, E., Goodwin, G.M., Bowden, C., Licht, R.W., Moller, H.J., ...Kasper, S. (2010). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2010 on the treatment of acute bipolar depression. World Journal of Biological Psychiatry, 11, 81–109.
   PubMed Web of Science ®Google Scholar
• Hallam, K.T., Smith, D.I. & Berk, M. (2009). Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression. Journal of Affective Disorders, 112, 212–218.
   PubMedGoogle Scholar
• Haskett, R.F. & Loo, C. (2010). Adjunctive psychotropic medications during electroconvulsive therapy in the treatment of depression, mania, and schizophrenia. Journal of ECT, 26, 196–201.
   PubMed Web of Science ®Google Scholar
• Hausner, L., Damian, M., Sartorius, A. & Frolich, L. (2011). Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. Journal of Clinical Psychiatry, 72, 91–97.
   PubMed Web of Science ®Google Scholar
• Heijnen, W., Birkenhager, T., Wierdsma, A. & Van Den Broek, W. (2010). Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: A meta-analysis. Journal of Clinical Psychopharmacology, 30, 616–619.
   PubMedGoogle Scholar
• Hoy, K. & Fitzgerald, P. (2010a). Brain stimulation in psychiatry and its effects on cognition. Nature Reviews Neurology, 6, 267–275.
   PubMedGoogle Scholar
• Hoy, K. & Fitzgerald, P. (2010b). Introducing magnetic seizure therapy: A novel therapy for treatment resistant depression. Australian and New Zealand Journal of Psychiatry, 44, 591–598.
   PubMed Web of Science ®Google Scholar
• Kayser, S., Bewernick, B., Axmacher, N. & Schlaepfer, T.E. (2009). Magnetic seizure therapy of treatment-resistant depression in a patient with bipolar disorder. Journal of ECT, 25, 137–140.
   PubMed Web of Science ®Google Scholar
• Kayser, S., Bewernick, B., Grubert, C., Hadrysiewicz, B., Axmacher, N. & Schlaepfer, T. (2011). Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. Journal of Psychiatric Research, 45, 569–576.
   PubMed Web of Science ®Google Scholar
• Kellner, C.H., Knapp, R., Husain, M.M., Rasmussen, K., Sampson, S., Cullum, M., McClintock, S.M., Tobias, K.G., Martino, C., Mueller, M., Bailine, S.H., Fink, M. & Petrides, G. (2010a). Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. British Journal of Psychiatry, 196, 226–234.
   PubMed Web of Science ®Google Scholar
• Kellner, C.H., Tobias, K.G. & Wiegand, J. (2010b). Electrode placement in electroconvulsive therapy (ECT): A review of the literature. Journal of ECT, 26, 175–180.
   PubMedGoogle Scholar
• Keltner, N.L. & Boschini, D.J. (2009). Electroconvulsive therapy. Perspectives in Psychiatric Care, 45, 66–70.
   PubMedGoogle Scholar
• Kennedy, S.H., Milev, R., Giacobbe, P., Ramasubbu, R., Lam, R.W., Parikh, S.V., Patten, S.B., & Ravindran, A.V. (2009). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. Journal of Affective Disorders, 117, S44–53).
   PubMedGoogle Scholar
• Kessler, U., Vaaler, A. E., Schoyen, H., Oedegaard, K.J., Bergsholm, P., Andreassen, O.A., Malt, U.F. & Morken, G. (2010). The study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder. BMC Psychiatry, 10, 16.
   PubMed Web of Science ®Google Scholar
• Kikuchi, A., Yasui-Furukori, N., Fujii, A., Katagai, H. & Kaneko, S. (2009). Identification of predictors of post-ictal delirium after electroconvulsive therapy. Psychiatry and Clinical Neurosciences, 63, 180–185.
   PubMed Web of Science ®Google Scholar
• Kimball, J.N., Rosenquist, P.B., Dunn, A. & McCall, V. (2009). Prediction of antidepressant response in both 2.25 × threshold RUL and fixed high dose RUL ECT. Journal of Affective Disorders, 112, 85–91.
   PubMedGoogle Scholar
• Kirov, G., Ebmeier, K., Scott, A., Atkins, M., Khalid, N., Carrick, L., Stanfield, A., O'Carroll, R., Husain, M. & Lisanby, S. (2008). Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. British Journal of Psychiatry, 193, 152–155.
   PubMed Web of Science ®Google Scholar
• Kirsch, I., Deacon, B.J., Huedo-Medina, T.B., Scoboria, A., Moore, T.J. & Johnson, B.T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5, e45.
   PubMed Web of Science ®Google Scholar
• Kosel, M., Frick, C., Lisanby, S., Fisch, H. & Schlaepfer, T. (2003). Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology, 28, 2045–2048.
   PubMed Web of Science ®Google Scholar
• Langius-Eklof, A. & Samuelsson, M. (2009). Sense of coherence and psychiatric morbidity in terms of anxiety and depression in patients with major depression before and after electric convulsive treatment. Scandinavian Journal of Caring Sciences, 23, 375–379.
   PubMedGoogle Scholar
• Lisanby, S. (2002). Update on magnetic seizure therapy: A novel form of convulsive therapy. Journal of ECT, 18, 182–188.
   PubMedGoogle Scholar
• Lisanby, S., Luber, B., Finck, A.D., Schroeder, C., & Sackeim, H.A. (2001a). Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Archives of General Psychiatry, 58, 199–200.
   PubMed Web of Science ®Google Scholar
• Lisanby, S., Luber, B., Schlaepfer, T. & Sackeim, H. (2003a). Safety and feasibility of magnetic seizure therapy (MST) in major depression: Randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology, 28, 1852–1865.
   PubMed Web of Science ®Google Scholar
• Lisanby, S., Morales, O., Payne, N., Kwon, E., Fitzsimons, L., Luber, B., Nobler, M. & Sackeim, H. (2003b). New developments in electroconvulsive therapy and magnetic seizure therapy. CNS Spectrums, 8, 529–536.
   PubMed Web of Science ®Google Scholar
• Lisanby, S., Moscrip, T., Morales, O., Luber, B., Schroeder, C. & Sackeim, H. (2003c). Neurophysiological characterization of magnetic seizure therapy (MST) in non-human primates. Supplements to Clinical Neurophysiology, 56, 81–99.
   PubMedGoogle Scholar
• Lisanby, S.H., Schlaepfer, T.E., Fisch, H.-U. & Sackeim, H.A. (2001b). Magnetic seizure therapy of major depression. Archives of General Psychiatry, 58, 303–305.
   PubMed Web of Science ®Google Scholar
• Loo, C.K., Sainsbury, K., Sheehan, P. & Lyndon, B. (2008). A comparison of RUL ultrabrief pulse (0.3 ms) ECT and standard RUL ECT. International Journal of Neuropsychopharmacology, 11, 883–890.
   PubMed Web of Science ®Google Scholar
• Malekian, A., Amini, Z., Maracy, M.R. & Barekatain, M. (2009). Knowledge of attitude toward experience and satisfaction with electroconvulsive therapy in a sample of Iranian patients. Journal of ECT, 25, 106–112.
   PubMed Web of Science ®Google Scholar
• Masdrakis, V.G., Florakis, A., Tzanoulinos, G., Markatou, M. & Oulis, P. (2010). Safety of the electroconvulsive therapy-ziprasidone combination. Journal of ECT, 26, 139–142.
   PubMedGoogle Scholar
• Mayur, P., Bray, A., Fernandes, J., Bythe, K. & Gilbett, D. (2010). Impact of hyperventilation on stimulus efficiency during the early phase of an electroconvulsive therapy course: a randomized double-blind study. Journal of ECT, 26, 91–94.
   PubMedGoogle Scholar
• McClintock, S.M., Cullum, M., Husain, M.M., Rush, A.J., Knapp, R.G., Mueller, M., Petrides, G., Sampson, S. & Kellner, C.H. (2010). Evaluation of the effects of severe depression on global cognitive function and memory. CNS Spectrums, 15, 304–313.
   PubMedGoogle Scholar
• McCormick, L.M., Brumm, M.C., Benede, A.K. & Lewis, J.L. (2009a). Relative ineffectiveness of ultrabrief right unilateral versus bilateral electroconvulsive therapy in depression. Journal of ECT, 25, 238–242.
   PubMedGoogle Scholar
• McCormick, L.M., Yamada, T., Yeh, M., Brumm, M.C. & Thatcher, R.W. (2009b). Antipsychotic effect of electroconvulsive therapy is related to normalization of subgenual cingulate theta activity in psychotic depression. Journal of Psychiatric Research, 43, 553–560.
   PubMed Web of Science ®Google Scholar
• Medda, P., Perugi, G., Zanello, S., Ciuffa, M. & Cassano, G.B. (2009). Response to ECT in bipolar I, bipolar II and unipolar depression. Journal of Affective Disorders, 118, 55–59.
   PubMed Web of Science ®Google Scholar
• Medda, P., Perugi, G., Zanello, S., Ciuffa, M., Rizzato, S., & Cassano, G.B. (2010). Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state. Journal of ECT, 26, 82–86.
   PubMed Web of Science ®Google Scholar
• Merkl, A., Heuser, I. & Bajbouj, M. (2009). Antidepressant electroconvulsive therapy: Mechanism of action, recent advances and limitations. Experimental Neurology, 219, 20–26.
   PubMed Web of Science ®Google Scholar
• Moksnes, K.M. & Ilner, S.O. (2010). Electroconvulsive therapy – Efficacy and side effects. Tidsskrift for Den Norske Laegeforening, 130, 2460–2464.
   PubMedGoogle Scholar
• Morales, O., Sackeim, H., Berman, R. & Lisanby, S. (2004). Magnetic seizure therapy: Development of a novel intervention for treatment resistant depression. Clinical Neuroscience Research, 42, 59–70.
   Google Scholar
• Moreines, J.L., McClintock, S.M. & Holtzheimer, P.E. (2011). Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: A review. Brain Stimulation, 4, 17–27.
   PubMed Web of Science ®Google Scholar
• Moscrip, T.D., Terrace, H.S., Sackeim, H.A. & Lisanby, S.H. (2006). Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). Int J Neuropsychopharmacol, 9, 1–11.
   PubMed Web of Science ®Google Scholar
• Mueller, P.S., Albin, S.M., Barnes, R.D. & Rasmussen, K.G. Jr. (2009). Safety of electroconvulsive therapy in patients with unrepaired abdominal aortic aneurysm: Report of eight patients. Journal of ECT, 25, 165–169.
   PubMedGoogle Scholar
• Nakajima, S., Ishida, T., Akaishi, R., Takahata, K., Kitahata, R., Uchida, H., Suzuki, T., Takeuchi, H., Nomura, K., Nakagawa, A., Watanabe, K. & Kashima, H. (2009). Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: A chart review. Journal of ECT, 25, 178–181.
   PubMedGoogle Scholar
• NICE (2003). Technology appraisal (TA59): The clinical effectiveness and cost effectiveness of electroconvulsive therapy (ECT) for depressive illness, schizophrenia, catatonia and mania. Available at: http://www.nice.org.uk/TA059.
   Google Scholar
• Nordanskog, P., Dahlstrand, U., Larsson, M.R., Larsson, E.M., Knutsson, L. & Johanson, A. (2010). Increase in hippocampal volume after electroconvulsive therapy in patients with depression: A volumetric magnetic resonance imaging study. Journal of ECT, 26, 62–67.
   PubMed Web of Science ®Google Scholar
• O'Connor, D.W., Gardner, B., Eppingstall, B. & Tofler, D. (2010a). Cognition in elderly patients receiving unilateral and bilateral electroconvulsive therapy: A prospective, naturalistic comparison. Journal of Affective Disorders, 124, 235–240.
   PubMedGoogle Scholar
• O'Connor, D.W., Gardner, B., Presnell, I., Singh, D., Tsanglis, M. & White, E. (2010b). The effectiveness of continuation-maintenance ECT in reducing depressed older patients’ hospital re-admissions. Journal of Affective Disorders, 120, 62–66.
   PubMedGoogle Scholar
• Okazaki, M., Tominaga, K., Higuchi, H., Utagawa, I., Nakamura, E., Noguchi, M., Itaya, M., Hashimoto, C. & Yamaguchi, N. (2010). Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg Depression Rating Scale for treatment-resistant depressed patients. Journal of ECT, 26, 87–90.
   PubMedGoogle Scholar
• Palmio, J., Huuhka, M., Laine, S., Huhtala, H., Peltola, J., Leinonen, E., Suhonen, J. & Keranen, T. (2010). Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein. Psychiatry Research, 177, 97–100.
   PubMed Web of Science ®Google Scholar
• Petrides, G., Braga, R. J., Fink, M., Mueller, M., Knapp, R., Husain, M., Rummans, T., Bailine, S., Malur, C., O'Connor, K., Kellner, C. & Group, C. (2009). Seizure threshold in a large sample: Implications for stimulus dosing strategies in bilateral electroconvulsive therapy: A report from CORE. Journal of ECT, 25, 232–237.
   PubMed Web of Science ®Google Scholar
• Petrides, G., Fink, M., Husain, M.M., Knapp, R.G., Rush, A. J., Mueller, M., Rummans, T.A., O'Connor, K.M., Rasmussen, K.G. Jr., Bernstein, H.J., Biggs, M., Bailine, SH. & Kellner, C.H. (2001). ECT remission rates in psychotic versus nonpsychotic depressed patients: A report from CORE. Journal of ECT, 17, 244–253.
   PubMed Web of Science ®Google Scholar
• Piccinni, A., Del Debbio, A., Medda, P., Bianchi, C., Roncaglia, I., Veltri, A., Zanello, S., Massimetti, E., Origlia, N., Domenici, L., Marazziti, D. & Dell'Osso, L. (2009). Plasma brain-derived neurotrophic factor in treatment-resistant depressed patients receiving electroconvulsive therapy. European Neuropsychopharmacology, 19, 349–355.
   PubMed Web of Science ®Google Scholar
• Plakiotis, C., Chin, L.F., O'Connor, D.W. & Victorian Aged Psychiatry Research Network. (2010). The change in electrical energy delivered to aged patients over a course of moderate dose unilateral electroconvulsive therapy. Psychogeriatrics, 10, 187–190.
   PubMedGoogle Scholar
• Popeo, D.M. (2009). Electroconvulsive therapy for depressive episodes: A brief review. Geriatrics, 64, 9–12.
   PubMed Web of Science ®Google Scholar
• Quante, A., Luborzewski, A., Brakemeier, E.L., Merkl, A., Danker-Hopfe, H. & Bajbouj, M. (2011). Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: A randomized, double-blind pilot study. Journal of Psychiatric Research, 45, 174–178.
   PubMedGoogle Scholar
• Rai, S., Kivisalu, T., Rabheru, K. & Kang, N. (2010). Electroconvulsive therapy clinical database: A standardized approach in tertiary care psychiatry. Journal of ECT, 26, 304–309.
   PubMedGoogle Scholar
• Rasmussen, K.G. (2009). Sham electroconvulsive therapy studies in depressive illness: A review of the literature and consideration of the placebo phenomenon in electroconvulsive therapy practice. Journal of ECT, 25, 54–59.
   PubMed Web of Science ®Google Scholar
• Rasmussen, K.G. & Black, J.L. (2009). Serotonin transporter gene status and electroconvulsive therapy outcomes: A retrospective analysis of 83 patients. Journal of Clinical Psychiatry, 70, 92–94.
   PubMed Web of Science ®Google Scholar
• Rasmussen, K.G., Mueller, M., Rummans, T.A., Husain, M.M., Petrides, G., Knapp, R.G., Fink, M., Sampson, S.M., Bailine, S.H. & Kellner, C .H. (2009). Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE). Journal of Clinical Psychiatry, 70, 232–237.
   PubMed Web of Science ®Google Scholar
• Rau, A., Grossheinrich, N., Palm, U., Pogarell, O. & Padberg, F. (2007). Transcranial and deep brain stimulation approaches as treatment for depression. Clinical EEG and Neuroscience, 38, 105–115.
   PubMedGoogle Scholar
• Read, J. & Bentall, R. (2010). The effectiveness of electroconvulsive therapy: A literature review. Epidemiologia e Psichiatria Sociale, 19, 333–347.
   PubMed Web of Science ®Google Scholar
• Rowny, S., Benzl, K. & Lisanby, S. (2009). Translational development strategy for magnetic seizure therapy. Experimental Neurology, 219, 27–35.
   PubMed Web of Science ®Google Scholar
• Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Stewart, J.W., Nierenberg, A.A., Thase, M.E., Ritz, L., Biggs, M.M., Warden, D., Luther, J.F., Shores-Wilson, K., Niederehe, G., & Fava, M. (2006). Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med, 354, 1231–1242.
   PubMed Web of Science ®Google Scholar
• Sackeim, H.A., Dillingham, E.M., Prudic, J., Cooper, T., McCall, W.V., Rosenquist, P., Isenberg, K., Garcia, K., Mulsant, B.H. & Haskett, R.F. (2009). Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: Short-term efficacy and adverse effects. Archives of General Psychiatry, 66, 729–737.
   PubMed Web of Science ®Google Scholar
• Sackeim, H.A., Haskett, R.F., Mulsant, B.H., Thase, M.E., Mann, J.J., Pettinati, H.M., Greenberg, R.M., Crowe, R.R., Cooper, T.B. & Prudic, J. (2001). Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: A randomized controlled trial. Journal of the American Medical Association, 285, 1299–1307.
   PubMed Web of Science ®Google Scholar
• Sackeim, H.A., Prudic, J., Devanand, D., Nobler, M. S., Lisanby, S.H., Peyser, S., Fitzsimons, L., Moody, B.J. & Clark, J. (2000). A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Archives of General Psychiatry, 57, 425–434.
   PubMed Web of Science ®Google Scholar
• Saijo, T., Takano, A., Suhara, T., Arakawa, R., Okumura, M., Ichimiya, T., Ito, H. & Okubo, Y. (2010a). Effect of electroconvulsive therapy on 5-HT1A receptor binding in patients with depression: A PET study with [11C]WAY 100635. International Journal of Neuropsychopharmacology, 13, 785–791.
   PubMed Web of Science ®Google Scholar
• Saijo, T., Takano, A., Suhara, T., Arakawa, R., Okumura, M., Ichimiya, T., Ito, H. & Okubo, Y. (2010b). Electroconvulsive therapy decreases dopamine D2receptor binding in the anterior cingulate in patients with depression: A controlled study using positron emission tomography with radioligand. Journal of Clinical Psychiatry, 71, 793–799.
   PubMedGoogle Scholar
• Savitz, J., Lucki, I. & Drevets, W.C. (2009). 5-HT(1A) receptor function in major depressive disorder. Progress in Neurobiology, 88, 17–31.
   PubMed Web of Science ®Google Scholar
• Scott, A. (2004). The ECT Handbook. In A. Scott (Ed.), The Third Report of the Royal College of Psychiatrists’ Special Committee on ECT. 4, 12, 15, 144–155
   Google Scholar
• Semkovska, M. & McLoughlin, D.M. (2010). Objective cognitive performance associated with electroconvulsive therapy for depression: A systematic review and meta-analysis. Biological Psychiatry, 68, 568–577.
   PubMed Web of Science ®Google Scholar
• Shelton, R.C., Osuntokun, O., Heinloth, A.N. & Corya, S.A. (2010). Therapeutic options for treatment-resistant depression. CNS Drugs, 24, 131–161.
   PubMed Web of Science ®Google Scholar
• Sienaert, P., Vansteelandt, K., Demyttenaere, K. & Peuskens, J. (2009a). Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Clinical efficacy. Journal of Affective Disorders, 116, 106–112.
   PubMed Web of Science ®Google Scholar
• Sienaert, P., Vansteelandt, K., Demyttenaere, K. & Peuskens, J. (2009b). Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: Differences in speed of response. Bipolar Disorders, 11, 418–424.
   PubMed Web of Science ®Google Scholar
• Sienaert, P., Vansteelandt, K., Demyttenaere, K. & Peuskens, J. (2010a). Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Cognitive side-effects. Journal of Affective Disorders, 122, 60–67.
   PubMedGoogle Scholar
• Sienaert, P.A., Vansteelandt, K., Demyttenaere, K. & Peuskens, J. (2010b). Predictors of patient satisfaction after ultrabrief bifrontal and unilateral electroconvulsive therapies for major depression. Journal of ECT, 26, 55–59.
   PubMed Web of Science ®Google Scholar
• Smith, G., Rasmussen, K. Jr., Cullum, C., Felmlee-Devine, M., Petrides, G., Rummans, T., Husain, M., Mueller, M., Bernstein, H., Knapp, R., O'Connor, M., Fink, M., Sampson, S., Bailine, S. & Kellner, C. (2010). A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: Results from the Consortium for Research in ECT (CORE) study. Journal of Clinical Psychiatry, 71, 185–193.
   PubMed Web of Science ®Google Scholar
• Spellman, T., McClintock, S.M., Terrace, H., Luber, B., Husain, M.M. & Lisanby, S.H. (2008). Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biol Psychiatry, 63, 1163–1170.
   PubMed Web of Science ®Google Scholar
• Sporn, A. & Lisanby, S. (2006). Non-pharmacological treatment modalities in children and adolescents: A review of electroconvulsive therapy, transcranial magnetic stimulation, vagus nerve stimulation, magnetic seizure therapy, and deep brain stimulation. Clinical Neuropsychiatry, 3, 230–244.
   Google Scholar
• Stanford, A., Husain, M., Luber, B., Berman, R., Truesdale, M., McClintock, S. & Lisanby, S.H. (2005). Magnetic seizure therapy and other convulsive therapies. Primary Psychiatry, 12, 44–50.
   Google Scholar
• Stewart, J., Kampman, O., Huuhka, M., Anttila, S., Huuhka, K., Lehtimaki, T. & Leinonen, E. (2009). ACE polymorphism and response to electroconvulsive therapy in major depression. Neuroscience Letters, 458, 122–125.
   PubMed Web of Science ®Google Scholar
• Thirthalli, J., Kumar, C.N., Bangalore, R.P. & Gangadhar, B.N. (2009). Speed of response to threshold and suprathreshold bilateral ECT in depression, mania and schizophrenia. Journal of Affective Disorders, 117, 104–107.
   PubMed Web of Science ®Google Scholar
• Trivedi, M.H., Fava, M., Wisniewski, S.R., Thase, M. E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A. A., Lebowitz, B. D., Biggs, M.M., Luther, J.F., Shores-Wilson, K., Rush, A.J. & STAR*D Study Team. (2006a). Medication augmentation after the failure of SSRIs for depression. New England Journal of Medicine, 354, 1243–1252.
   PubMed Web of Science ®Google Scholar
• Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P.J., Shores-Wilson, K., Biggs, M. M., Balasubramani, G.K., Fava, M. & STAR*D Study Team. (2006b). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry, 163, 28–40.
   PubMed Web of Science ®Google Scholar
• Valevski, A., Pickholtz, E., Roz, N., Weizman, A. & Rehavi, M. (2010). Lack of modulatory effect of short-term repeated electroconvulsive therapy on platelet vesicular monoamine transporter 2 (VMAT2) in depressed patients. Journal of Neural Transmission, 117, 881–885.
   PubMedGoogle Scholar
• van Waarde, J.A., Wielaard, D., Wijkstra, J., Verwey, B. & van der Mast, R.C. (2010). Retrospective study of continuation electroconvulsive therapy in 50 patients. Journal of ECT, 26, 299–303.
   PubMedGoogle Scholar
• Viikki, M., Anttila, S., Kampman, O., Illi, A., Huuhka, M., Setälä-Soikkeli, E., Mononen, N., Lehtimäki, T. & Leinonen, E. (2010a). Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression. Neuroscience Letters, 477, 105–108.
   PubMed Web of Science ®Google Scholar
• Viikki, M., Kampman, O., Illi, A., Setala-Soikkeli, E., Anttila, S., Huuhka, M., Nuolivirta, T., Poutanen, O., Mononen, N., Lehtimaki, T. & Leinonen, E. (2010b). TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response. Neuroscience Letters, 468, 80–84.
   PubMed Web of Science ®Google Scholar
• White, P., Amos, Q., Zhang, Y., Stool, L., Husain, M., Thornton, L., Downing, M., McClintock, S. & Lisanby, S. (2006). Anesthetic considerations for magnetic seizure therapy: A novel therapy for severe depression. Anesthesia and Analgesia, 103, 76–80.
   PubMed Web of Science ®Google Scholar
• Yatham, L.N., Kennedy, S.H., Schaffer, A., Parikh, S.V., Beaulieu, S., O'Donovan, C., MacQueen, G., McIntyre, R.S., Sharma, V., Ravindran, A., Young, L.T., Young, A.H., Alda, M., Milev, R., Vieta, E., Calabrese, J.R., Berk, M., Ha, K. & Kapczinski, F. (2009). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2009. Bipolar Disorders, 11(3), 225–255.
   PubMedGoogle Scholar
• Yatham, L.N., Liddle, P.F., Lam, R.W., Zis, A.P., Stoessl, A.J., Sossi, V., Adam, M.J. & Ruth, T.J. (2010). Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depression. British Journal of Psychiatry, 196, 474–479.
   PubMedGoogle Scholar
• Yildiz, A., Mantar, A., Simsek, S., Onur, E., Gokmen, N. & Fidaner, H. (2010). Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: A pilot controlled trial. Journal of ECT, 26, 104–110.
   PubMedGoogle Scholar
• Zhang, X., Zhang, Z., Sha, W., Xie, C., Xi, G., Zhou, H. & Zhang, Y. (2009). Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression. Psychiatry Research, 170, 273–275.
   PubMed Web of Science ®Google Scholar
• Zyss, T., Zieba, A., Hese, R., Dudek, D., Grabski, B., Gorczyca, P. & Modrzejewska, R. (2010). Magnetic seizure therapy (MST) – A safer method for evoking seizure activity than current therapy with a confirmed antidepressant efficacy. Neuroendocrinology Letters, 31, 425–437.
   PubMedGoogle Scholar